BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10856626)

  • 1. Quantification of microbubble destruction of three fluorocarbon-filled ultrasonic contrast agents.
    Moran CM; Anderson T; Pye SD; Sboros V; McDicken WN
    Ultrasound Med Biol; 2000 May; 26(4):629-39. PubMed ID: 10856626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro acoustic characterisation of four intravenous ultrasonic contrast agents at 30 MHz.
    Moran CM; Watson RJ; Fox KA; McDicken WN
    Ultrasound Med Biol; 2002 Jun; 28(6):785-91. PubMed ID: 12113791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Needle and Catheter Size on Commercially Available Ultrasound Contrast Agents.
    Eisenbrey JR; Daecher A; Kramer MR; Forsberg F
    J Ultrasound Med; 2015 Nov; 34(11):1961-8. PubMed ID: 26384606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time contrast ultrasound muscle perfusion imaging with intermediate-power imaging coupled with acoustically durable microbubbles.
    Seol SH; Davidson BP; Belcik JT; Mott BH; Goodman RM; Ammi A; Lindner JR
    J Am Soc Echocardiogr; 2015 Jun; 28(6):718-26.e2. PubMed ID: 25769666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of the size distribution and myocardial contrast effect of perfluorocarbon-filled albumin microbubbles by lyophilization under continuous negative pressure.
    Chen S; Wang Z; Zhou YT; Grayburn PA
    J Am Soc Echocardiogr; 2000 Aug; 13(8):748-53. PubMed ID: 10936818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the usefulness of the mechanical index displayed on clinical ultrasound scanners for predicting contrast microbubble destruction.
    Forsberg F; Shi WT; Merritt CR; Dai Q; Solcova M; Goldberg BB
    J Ultrasound Med; 2005 Apr; 24(4):443-50. PubMed ID: 15784762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary clinical experience in cardiology with sonazoid.
    Marelli C
    Am J Cardiol; 2000 Aug; 86(4A):10G-13G. PubMed ID: 10997345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.
    Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in definity and optison microbubble destruction rates at a similar mechanical index with different real-time perfusion systems.
    Sonne C; Xie F; Lof J; Oberdorfer J; Phillips P; Carr Everbach E; Porter TR
    J Am Soc Echocardiogr; 2003 Nov; 16(11):1178-85. PubMed ID: 14608290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Method to Quantify Concentration of Microbubbles in Attenuating Media Using Bubble Destruction Curve Analysis of the Contrast-Enhanced Ultrasound.
    Kamiyama N; Wakui N; Oguri T; Hashimoto H; Kanayama Y; Nagai H
    Ultrasound Med Biol; 2019 Sep; 45(9):2485-2492. PubMed ID: 31239150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ultrasound contrast agents on Doppler tissue velocity estimation.
    Ressner M; Brodin LA; Jansson T; Hoff L; Ask P; Janerot-Sjoberg B
    J Am Soc Echocardiogr; 2006 Feb; 19(2):154-64. PubMed ID: 16455419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo study of microbubbles as an MR susceptibility contrast agent.
    Wong KK; Huang I; Kim YR; Tang H; Yang ES; Kwong KK; Wu EX
    Magn Reson Med; 2004 Sep; 52(3):445-52. PubMed ID: 15334560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiographic Ischemic Memory Imaging Through Complement-Mediated Vascular Adhesion of Phosphatidylserine-Containing Microbubbles.
    Mott B; Packwood W; Xie A; Belcik JT; Taylor RP; Zhao Y; Davidson BP; Lindner JR
    JACC Cardiovasc Imaging; 2016 Aug; 9(8):937-46. PubMed ID: 27318722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subharmonic generation from ultrasonic contrast agents.
    Krishna PD; Shankar PM; Newhouse VL
    Phys Med Biol; 1999 Mar; 44(3):681-94. PubMed ID: 10211802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the effect of lung filtering and cardiac pressure on the standard properties of ultrasound contrast agent.
    Bouakaz A; de Jong N; Cachard C; Jouini K
    Ultrasonics; 1998 Feb; 36(1-5):703-8. PubMed ID: 9651600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between microbubbles and ultrasound: in vitro and in vivo observations.
    Wei K; Skyba DM; Firschke C; Jayaweera AR; Lindner JR; Kaul S
    J Am Coll Cardiol; 1997 Apr; 29(5):1081-8. PubMed ID: 9120163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cavitation threshold of microbubbles in gel tunnels by focused ultrasound.
    Sassaroli E; Hynynen K
    Ultrasound Med Biol; 2007 Oct; 33(10):1651-60. PubMed ID: 17590501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The behaviour of individual contrast agent microbubbles.
    Sboros V; Moran CM; Pye SD; McDicken WN
    Ultrasound Med Biol; 2003 May; 29(5):687-94. PubMed ID: 12754068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive vessel-selective perfusion imaging with intravenous myocardial contrast echocardiography.
    Asanuma T; Fujihara T; Otani K; Miki A; Ishikura F; Beppu S
    J Am Soc Echocardiogr; 2004 Jun; 17(6):654-8. PubMed ID: 15163938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
    Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
    J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.